Protein kinases - The major drug targets of the twenty-first century?

    Research output: Contribution to journalArticlepeer-review

    1950 Citations (Scopus)


    Protein phosphorylation regulates most aspects of cell life, whereas abnormal phosphorylation is a cause or consequence of disease. A growing interest in developing orally active protein-kinase inhibitors has recently culminated in the approval of the first of these drugs for clinical use. Protein kinases have now become the second most important group of drug targets, after G-protein-coupled receptors. Here, I give a personal view of some of the most important advances that have shaped this field.

    Original languageEnglish
    Pages (from-to)309-315
    Number of pages7
    JournalNature Reviews Drug Discovery
    Issue number4
    Publication statusPublished - 1 Apr 2002

    ASJC Scopus subject areas

    • Pharmacology
    • Drug Discovery


    Dive into the research topics of 'Protein kinases - The major drug targets of the twenty-first century?'. Together they form a unique fingerprint.

    Cite this